Literature DB >> 9281856

Influence of various bile salts on beta-glucuronidase activity of intestinal bacteria.

T Fujisawa1, M Mori.   

Abstract

While the decrease of the beta-glucuronidase activity of sonicated cells of Clostridium perfringens and Escherichia coli was obvious for sodium deoxycholate (DC), it was not so obvious for other bile salts (sodium glycocholate and sodium cholate). The enzyme activity of intact cells of these bacteria was significantly enhanced by the presence of DC, but not by the other bile salts in the buffer. These results suggest that the permeability of the bacterial cells is increased more by the presence of DC than by other bile salts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9281856     DOI: 10.1046/j.1472-765x.1997.00180.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  5 in total

1.  Comparative study of fluorogenic and chromogenic media for specific detection of environmental isolates of thermotolerant Escherichia coli.

Authors:  Pramod W Ramteke; Suman Tewari
Journal:  Environ Monit Assess       Date:  2002-10       Impact factor: 2.513

2.  Bile Salts Differentially Enhance Resistance of Enterohemorrhagic Escherichia coli O157:H7 to Host Defense Peptides.

Authors:  Crystal Gadishaw-Lue; Alyssa Banaag; Sarah Birstonas; Aju-Sue Francis; Debora Barnett Foster
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

Review 3.  Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.

Authors:  Femke M de Man; Andrew K L Goey; Ron H N van Schaik; Ron H J Mathijssen; Sander Bins
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

Review 4.  Physiology and Physical Chemistry of Bile Acids.

Authors:  Maria Chiara di Gregorio; Jacopo Cautela; Luciano Galantini
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 5.923

5.  CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas.

Authors:  Ling-Chun Chen; Wei-Jie Cheng; Shyr-Yi Lin; Ming-Tse Hung; Ming-Thau Sheu; Hong-Liang Lin; Chien-Ming Hsieh
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.